Are antimicrobial-impregnated catheters effective? When does repetition reach the point of exhaustion?

[1]  E. Anaissie,et al.  Are antimicrobial-impregnated catheters effective? Replace the water and grab your washcloth, because we have a baby to wash. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  Peter J Pronovost,et al.  Eliminating catheter-related bloodstream infections in the intensive care unit* , 2004, Critical care medicine.

[3]  H. Kantarjian,et al.  Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  E. Anaissie,et al.  Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia? , 2004, The Lancet. Infectious diseases.

[5]  D. Maki,et al.  Are antimicrobial-impregnated catheters effective? Don't throw out the baby with the bathwater. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  D. Maki,et al.  The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters , 2004, Intensive Care Medicine.

[7]  S. Saint,et al.  Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  A. Shorr,et al.  New Choices for Central Venous Catheters , 2003 .

[9]  A. Shorr,et al.  New choices for central venous catheters: potential financial implications. , 2003, Chest.

[10]  E. Anaissie,et al.  Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection? , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  A. Shorr,et al.  Cost-effectiveness of Linezolid for Treatment of Ventilator-Associated Pneumoni , 2003 .

[12]  Dan M. Kluger,et al.  A Review of Risk Factors for Catheter-Related Bloodstream Infection Caused by Percutaneously Inserted, Noncuffed Central Venous Catheters: Implications for Preventive Strategies , 2002, Medicine.

[13]  Richard Sylvester,et al.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. , 2002, The New England journal of medicine.

[14]  E. Anaissie,et al.  The hospital water supply as a source of nosocomial infections: a plea for action. , 2002, Archives of internal medicine.

[15]  D. Maki,et al.  The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  D. Maki,et al.  The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  E. Anaissie,et al.  Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. , 2002, The New England journal of medicine.

[18]  D. Maki,et al.  The role of intravascular devices in sepsis , 2001, Current infectious disease reports.

[19]  C. Brun-Buisson,et al.  Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. , 2001, American journal of respiratory and critical care medicine.

[20]  L. Mahieu,et al.  Risk factors for central vascular catheter-associated bloodstream infections among patients in a neonatal intensive care unit. , 2001, The Journal of hospital infection.

[21]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[22]  R Consunji,et al.  Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. , 2001, Archives of surgery.

[23]  E. Anaissie,et al.  A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile Neutropenia , 2000 .

[24]  J. Rello,et al.  Evaluation of outcome of intravenous catheter-related infections in critically ill patients. , 2000, American journal of respiratory and critical care medicine.

[25]  P. Hsueh,et al.  Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients. , 2000, Diagnostic microbiology and infectious disease.

[26]  J. Skurnick,et al.  Prevention of nosocomial bloodstream infections: Effectiveness of antimicrobial-impregnated and heparin-bonded central venous catheters , 2000, Critical care medicine.

[27]  D. Pittet,et al.  Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care , 2000, The Lancet.

[28]  Robert Sherertz,et al.  Education of Physicians-in-Training Can Decrease the Risk for Vascular Catheter Infection , 2000, Annals of Internal Medicine.

[29]  M. Kaufmann,et al.  Origins of Staphylococcus epidermidis and Streptococcus oralis causing bacteraemia in a bone marrow transplant patient. , 2000, Journal of medical microbiology.

[30]  D. Kluger.  A meta-analysis of the risk of intravascular device-related blood stream infection based on 223 published prospective studies , 2000 .

[31]  E. Anaissie,et al.  A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  O. Wenker,et al.  Comparison of Two Antimicrobial—Impregnated Central Venous Catheters , 1999 .

[33]  Hannan,et al.  Antiseptic‐bonded central venous catheters and bacterial colonisation , 1999, Anaesthesia.

[34]  M. Higgins,et al.  The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. , 1999, American journal of respiratory and critical care medicine.

[35]  S. Saint,et al.  Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. , 1999, JAMA.

[36]  S Chevret,et al.  Attributable Morbidity and Mortality of Catheter-Related Septicemia in Critically Ill Patients: a Matched, Risk-Adjusted, Cohort Study , 1999, Infection Control & Hospital Epidemiology.

[37]  P. Marik,et al.  The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters. , 1999, Critical care medicine.

[38]  G. Collin.  Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. , 1999, Chest.

[39]  T. Lumley,et al.  Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. , 1999, JAMA.

[40]  Denilson Barbosa,et al.  Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. , 1998, Journal of the American Society of Nephrology : JASN.

[41]  E. Anaissie,et al.  Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  J. Puyana,et al.  Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. , 1998, Archives of internal medicine.

[43]  M. Lieser,et al.  A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections. , 1997, Archives of surgery.

[44]  W. D’hoore,et al.  Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. , 1997, The Journal of hospital infection.

[45]  L. Mermel,et al.  Prevention of Central Venous Catheter-Related Bloodstream Infection by Use of an Antiseptic-Impregnated Catheter , 1997, Annals of Internal Medicine.

[46]  D. Cook,et al.  Central venous catheter replacement strategies: a systematic review of the literature. , 1997, Critical care medicine.

[47]  P. Vuddamalay,et al.  Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients. , 1997, European journal of anaesthesiology.

[48]  A. Gabrielli,et al.  Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. , 1997, Annals of internal medicine.

[49]  P. Cuddy,et al.  No difference in catheter sepsis between standard and antiseptic central venous catheters. A prospective randomized trial. , 1996, Archives of surgery.

[50]  P. Volkers,et al.  Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. , 1996, The American surgeon.

[51]  P. V. van Heerden,et al.  Central Venous Catheters Revisited— Infection Rates and an Assessment of the New Fibrin Analysing System Brush , 1996, Anaesthesia and intensive care.

[52]  E. Martin,et al.  Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters. , 1996, The Journal of antimicrobial chemotherapy.

[53]  T. Kuhn.  The structure of scientific revolutions, 3rd ed. , 1996 .

[54]  P. Reiser,et al.  EXAMINATION OF ANTIMICROBIAL COATED CENTRAL VENOUS CATHETERS IN PATIENTS AT HIGH RISK FOR CATHETER RELATED INFECTIONS IN A MEDICAL INTENSIVE CARE UNIT AND LEUKEMIA/BONE MARROW TRANSPLANT UNIT , 1995 .

[55]  P. Collignon.  Intravascular catheter associated sepsis: a common problem , 1994 .

[56]  E. Martin,et al.  REDUCTION OF BACTERIAL COLONIZATION OF TRIPLE-LUMEN CATHETERS WITH ANTISEPTIC BONDING IN SEPTIC PATIENTS , 1994 .

[57]  M. Ringer,et al.  Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters , 1994 .

[58]  M. Cosio,et al.  The Bullard laryngoscope and size of the endotracheal tube. , 1994, Anesthesiology.

[59]  Didier Pittet,et al.  Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. , 1994, JAMA.

[60]  M. Moro,et al.  Risk factors for central venous catheter-related infections in surgical and intensive care units. The Central Venous Catheter-Related Infections Study Group. , 1994, Infection control and hospital epidemiology.

[61]  J. Ramsay,et al.  Incidence of catheter colonization and catheter related infection with an antiseptic impregnated triple lumen catheter , 1994 .

[62]  M. Pfaller,et al.  Molecular epidemiology of coagulase-negative staphylococci isolated from immunocompromised patients. , 1992 .

[63]  M. Pfaller,et al.  Molecular Epidemiology of Coagulase-Negative Staphylococci Isolated From Immunocompromised Patients , 1992, Infection Control & Hospital Epidemiology.

[64]  C. Alvarado,et al.  Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters , 1991, The Lancet.

[65]  M. Simberkoff,et al.  Excess mortality in critically ill patients with nosocomial bloodstream infections. , 1991, Chest.

[66]  CDC definitions for nosocomial infections, 1988. , 1989, The American review of respiratory disease.

[67]  J M Hughes,et al.  CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.

[68]  T. Kuhn,et al.  The Structure of Scientific Revolutions. , 1964 .